These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
531 related articles for article (PubMed ID: 11328220)
1. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients. Obermair A; Sevelda P Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220 [TBL] [Abstract][Full Text] [Related]
2. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer. Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134 [TBL] [Abstract][Full Text] [Related]
3. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study. Williams L; Brunetto VL; Yordan E; DiSaia PJ; Creasman WT Gynecol Oncol; 1997 Aug; 66(2):171-8. PubMed ID: 9264559 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of second cytoreductive surgery in the treatment of epithelial ovarian cancer. Sun T; Feng Y Chin Med J (Engl); 1998 Mar; 111(3):272-4. PubMed ID: 10374433 [TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701 [TBL] [Abstract][Full Text] [Related]
6. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome. Salani R; Santillan A; Zahurak ML; Giuntoli RL; Gardner GJ; Armstrong DK; Bristow RE Cancer; 2007 Feb; 109(4):685-91. PubMed ID: 17219441 [TBL] [Abstract][Full Text] [Related]
7. [Significance of systematic retroperitoneal lymphadenectomy at second-look laparotomy for ovarian cancer]. Zhang ZY; Zang RY; Tang MQ; Chen J Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):69-71. PubMed ID: 12783690 [TBL] [Abstract][Full Text] [Related]
8. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649 [TBL] [Abstract][Full Text] [Related]
9. Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature. Bristow RE; Lagasse LD; Karlan BY Cancer; 1996 Nov; 78(10):2049-62. PubMed ID: 8918397 [TBL] [Abstract][Full Text] [Related]
10. [Value of tumor-reductive secondary operation (interventional laparotomy) in ovarian cancer]. Meier W; Römisch M; Hepp H Geburtshilfe Frauenheilkd; 1993 Dec; 53(12):860-5. PubMed ID: 8119569 [TBL] [Abstract][Full Text] [Related]
11. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer. Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445 [TBL] [Abstract][Full Text] [Related]
12. Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Linasmita V; Wilailak S; Thakkinstian A; Srisupundit S; Tangtrakul S; Israngura N; Bullangpoti S J Med Assoc Thai; 2001 Jul; 84(7):958-65. PubMed ID: 11759976 [TBL] [Abstract][Full Text] [Related]
13. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival. Friedman RL; Eisenkop SM; Wang HJ Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362 [TBL] [Abstract][Full Text] [Related]
14. The role of secondary cytoreductive surgery in epithelial ovarian malignancies. Williams L Oncology (Williston Park); 1992 Aug; 6(8):25-32; discussion 37-9. PubMed ID: 1386995 [TBL] [Abstract][Full Text] [Related]
15. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC). Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175 [TBL] [Abstract][Full Text] [Related]
16. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy. Bolis G; Villa A; Guarnerio P; Ferraris C; Gavoni N; Giardina G; Melpignano M; Scarfone G; Zanaboni F; Parazzini F Cancer; 1996 Jan; 77(1):128-31. PubMed ID: 8630918 [TBL] [Abstract][Full Text] [Related]
17. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP; J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437 [TBL] [Abstract][Full Text] [Related]
18. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Silva EG; Gershenson DM; Malpica A; Deavers M Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075 [TBL] [Abstract][Full Text] [Related]
19. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Chi DS; McCaughty K; Diaz JP; Huh J; Schwabenbauer S; Hummer AJ; Venkatraman ES; Aghajanian C; Sonoda Y; Abu-Rustum NR; Barakat RR Cancer; 2006 May; 106(9):1933-9. PubMed ID: 16572412 [TBL] [Abstract][Full Text] [Related]